D

Researcher Profile

David Fandrei

🏛 Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases Universitätsklinikum Leipzig Leipzig Germany

0009-0006-4014-6030

4

Publications

69

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Leukemia Feb 17, 2026

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

Thomas C. Wiemers · Nora Grieb · Maximilian Ferle · Michael Rade +25 more

10.1038/s41375-026-02887-5

Open Access Journal Article HemaSphere Jan 01, 2025

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

Maximilian Merz · Anca‐Maria Albici · Bastian von Tresckow · Kristin Rathje +25 more

10.1002/hem3.70070 35 citations

Journal Article Blood Oct 23, 2025

Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy

Binod Dhakal · Othman S. Akhtar · David Fandrei · Alexandria Jensen +39 more

10.1182/blood.2025029773 14 citations

Journal Article Nature Medicine Feb 21, 2025

Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody

Till Braun · Michael Rade · Maximilian Merz · Hanna Klepzig +19 more

10.1038/s41591-025-03499-9 20 citations

Publication Timeline

2026

1

2025

3

Frequent Co-Authors

Maximilian Merz

Uwe Platzbecker